Eone Diagnomics Genome Center to Secure 89.4 Billion Won through Stock Offering


On Friday, SEOUL-based Eone Diagnomics Genome Center declared that it will be raising 89.4 billion won (US$66.8 million) by selling stock. The funds are intended to be used to finance the company’s activities.

As per the official filing, the company will be distributing 74 million common shares at a price of 1,208 won per share. The stock will be distributed amongst the company’s shareholders.

You might also like
Open chat
Need help?
Scan the code
Hello 👋
Can we help you?

Mark Silaev
Glosema Account Manager